Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 250
Single User License Price INR 17293
Corporate User License Price USD 750
Corporate User License Price INR 51878
Site License Price USD 500
Site License Price INR 34585
Request a Quote

Report Title

Alzheimers Drug Discovery Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Quote Request for License Type
License Type Price  
Single User License USD 250
Site License USD 500
Enterprise Wide License USD 750
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Alzheimers Drug Discovery Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile


Quote Request for License Type
License Type Price  
Single User License USD 250
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Alzheimers Drug Discovery Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Alzheimers Drug Discovery Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile



Executive Summary

Summary

Alzheimer's Drug Discovery Foundation (ADDF), formerly Institute for the Study of Aging is a drug discovery foundation. The foundation offers funds for drug discovery and development research programs in the field of Alzheimer's disease, related dementias and cognitive aging. It offers services and support for development of drugs to prevent, treat, and cure Alzheimer's disease. ADDF provides grants to the recipients for the treatment of Alzheimer's disease. The foundation provides funds on preclinical research and early-stage clinical trials for new drug targets. It partners with various universities, and other research and development organizations. ADDF is headquartered in New York, the US.

Alzheimer's Drug Discovery Foundation-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deal Details 10

Venture Financing 10

M3 Biotechnology Raises USD15.2 Million in Venture Financing 10

M3 Biotech Raises USD1.4 Million in Second Round of Venture Financing 12

Partnerships 13

Alzheimer Drug Discovery Enters into Research Agreement with CTI for Alzheimer's Disease Drugs 13

Equity Offering 14

Oryzon Genomics Raises USD0.7 Million in Private Placement of Shares upon Exercise of Warrants 14

Alzheimer's Drug Discovery Foundation-Key Competitors 15

Alzheimer's Drug Discovery Foundation-Key Employees 16

Alzheimer's Drug Discovery Foundation-Locations And Subsidiaries 17

Head Office 17

Recent Developments 18

Government and Public Interest 18

May 10, 2018: USD 2.5 Million in New Funding Exemplifies ADDF's Strategy 18

Apr 12, 2018: Inaugural Memories Matter Benefit Raises USD 1.2 Million for Alzheimers Drug Research 21

Mar 28, 2018: Alzheimer's Drug Discovery Foundation and Harrington Discovery Institute Invite Applications for 2018 ADDF-Harrington Scholar Award 22

Mar 13, 2018: Funding Supports New Approaches to Treat Multiple Types of Dementia 23

Jan 09, 2018: Alzheimer's Drug Discovery Foundation: USD 2.5 Million in New Grants Advance Clinical Trials of Alzheimers Treatments 24

Jan 08, 2018: Alzheimer's Drug Discovery Foundation: USD 1.8 Million in New Funding Supports Clinical Stage Treatments 25

Jan 08, 2018: USD 1.8 Million in New Funding Supports Clinical Stage Treatments 27

Nov 14, 2017: Alzheimer's Drug Discovery Foundation Announces Three New Grants 29

Sep 12, 2017: Three New Grants Support Promising Treatments for Alzheimers Disease 30

Sep 05, 2017: New Funding Supports Blood Test for Early Alzheimer's 31

May 15, 2017: USD 2.6 Million in New Grants Spurs Innovation 32

Apr 20, 2017: ADDF-Funded Scientists Discover Two Repurposed Drugs With Promise for Alzheimers and FTD 35

Mar 07, 2017: USD 4 Million in New Grants Support Several First-in-class Dementia Treatments 36

Mar 01, 2017: Cypralis Announces Grant Award from Alzheimer's Drug Discovery Foundation 39

Jan 09, 2017: USD 2.5 Million in New Grants Advance Clinical Trials of Alzheimer's Treatments 40

Product News 42

Nov 01, 2017: New Report Highlights Innovation in Alzheimers Clinical Trials 42

Jun 07, 2017: The Alzheimer's Drug Discovery Foundation and Science Exchange Launch ADDF ACCESS to Advance CNS Research 43

Other Significant Developments 44

Jun 07, 2017: ADDF and Science Exchange Launch ADDF ACCESS to Advance Research 44

Appendix 45

Methodology 45

About GlobalData 45

Contact Us 45

Disclaimer 45

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

List of Tables

Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Key Facts, 2016 2

Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Alzheimer's Drug Discovery Foundation, Deals By Therapy Area, 2012 to YTD 2018 8

Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

M3 Biotechnology Raises USD15.2 Million in Venture Financing 10

M3 Biotech Raises USD1.4 Million in Second Round of Venture Financing 12

Alzheimer Drug Discovery Enters into Research Agreement with CTI for Alzheimer's Disease Drugs 13

Oryzon Genomics Raises USD0.7 Million in Private Placement of Shares upon Exercise of Warrants 14

Alzheimer's Drug Discovery Foundation, Key Competitors 15

Alzheimer's Drug Discovery Foundation, Key Employees 16

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Alzheimer's Drug Discovery Foundation, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person